These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 25857136)

  • 41. Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions.
    Prasad V; Baum RP
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):61-7. PubMed ID: 20168287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diagnostic criteria and classification of gastro-intestinal pancreatic endocrine tumors].
    Capella C; Uccella S; Albarello L; Feltri M; La Rosa S
    Minerva Endocrinol; 2001 Sep; 26(3):103-10. PubMed ID: 11753231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs.
    Kasajima A; Papotti M; Ito W; Brizzi MP; La Salvia A; Rapa I; Tachibana T; Yazdani S; Sasano H; Volante M
    Hum Pathol; 2018 Feb; 72():144-152. PubMed ID: 29180250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical significance of Smac and Ki-67 expression in pancreatic cancer.
    Hu HY; Liu H; Zhang JW; Hu K; Lin Y
    Hepatogastroenterology; 2012; 59(120):2640-3. PubMed ID: 22534537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The importance of clinical information in patients with gastroenteropancreatic neuroendocrine tumor.
    Kudo A; Akashi T; Kumagai J; Ban D; Inokuchi M; Kojima K; Kawano T; Tanaka S; Arii S
    Hepatogastroenterology; 2012; 59(120):2450-3. PubMed ID: 22584507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The continuing evolution of somatostatin receptor imaging in neuroendocrine tumours.
    Navalkissoor S; Buscombe JR
    Nucl Med Commun; 2011 Mar; 32(3):163-7. PubMed ID: 21266901
    [No Abstract]   [Full Text] [Related]  

  • 47. Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.
    Boninsegna L; Panzuto F; Partelli S; Capelli P; Delle Fave G; Bettini R; Pederzoli P; Scarpa A; Falconi M
    Eur J Cancer; 2012 Jul; 48(11):1608-15. PubMed ID: 22129889
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.
    Strosberg J; Nasir A; Coppola D; Wick M; Kvols L
    Hum Pathol; 2009 Sep; 40(9):1262-8. PubMed ID: 19368957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Symptomatic pure pancreatic polypeptide-containing tumor of the pancreas.
    Raffel A; Krausch M; Schulte KM; Röher HD
    Pancreas; 2004 Jul; 29(1):83. PubMed ID: 15211116
    [No Abstract]   [Full Text] [Related]  

  • 50. A Step Forward in PET-Based Quantitation of G3 Neuroendocrine Tumor Aggressiveness - The FDZ Score….
    Gerbaudo VH; Latif MA
    Acad Radiol; 2022 Sep; 29(9):1317-1319. PubMed ID: 35365399
    [No Abstract]   [Full Text] [Related]  

  • 51. Can radiomics outperform pathology for tumor grading?
    Ronot M; Soyer P
    Diagn Interv Imaging; 2024 Jan; 105(1):3-4. PubMed ID: 37714731
    [No Abstract]   [Full Text] [Related]  

  • 52. ASO Author Reflections: Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors.
    Lopez-Aguiar AG; Cardona K
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):826-827. PubMed ID: 30456670
    [No Abstract]   [Full Text] [Related]  

  • 53. Differences between Grades G1 and G2 Hypovascular Pancreatic Neuroendocrine Tumors and Pancreatic Neuroendocrine Carcinoma.
    Chen X; Wang Z
    Radiology; 2017 Oct; 285(1):331-332. PubMed ID: 28926309
    [No Abstract]   [Full Text] [Related]  

  • 54. ASO Author Reflections: Accuracy of Grading in Pancreatic Neuroendocrine Neoplasms and Effect on Survival Estimates: An Institutional Experience.
    Trikalinos NA; Chatterjee D
    Ann Surg Oncol; 2020 Sep; 27(9):3551-3552. PubMed ID: 32253674
    [No Abstract]   [Full Text] [Related]  

  • 55. Neuroendocrine neoplasm: Current understanding.
    Lila AR; Memon SS
    J Postgrad Med; 2023; 69(2):65-67. PubMed ID: 36960525
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinicopathologic characteristics of pancreatic neuroendocrine neoplasm].
    Okuwaki K; Kida M; Imaizumi H; Yamauchi H; Koizumi W
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():788-91. PubMed ID: 25857136
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors.
    Hasegawa T; Yamao K; Hijioka S; Bhatia V; Mizuno N; Hara K; Imaoka H; Niwa Y; Tajika M; Kondo S; Tanaka T; Shimizu Y; Kinoshita T; Kohsaki T; Nishimori I; Iwasaki S; Saibara T; Hosoda W; Yatabe Y
    Endoscopy; 2014 Jan; 46(1):32-8. PubMed ID: 24218309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diagnosis, histopathologic grading and prognostic moleculer marker analysis in patients with pancreatic neuroendocrine neoplasm].
    Bao F; Chen GR; Hui P; Cai GP
    Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):426-32. PubMed ID: 24060085
    [No Abstract]   [Full Text] [Related]  

  • 59. Somatostatin receptor 2 and 5 expressions in gastroenteropancreatic neuroendocrine tumors in Turkey.
    Yerci O; Sehitoglu I; Ugras N; Cubukcu E; Yuce S; Bedir R; Cure E
    Asian Pac J Cancer Prev; 2015; 16(10):4377-81. PubMed ID: 26028102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study.
    Larghi A; Capurso G; Carnuccio A; Ricci R; Alfieri S; Galasso D; Lugli F; Bianchi A; Panzuto F; De Marinis L; Falconi M; Delle Fave G; Doglietto GB; Costamagna G; Rindi G
    Gastrointest Endosc; 2012 Sep; 76(3):570-7. PubMed ID: 22898415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.